Loading candles…
Divis Laboratories Ltd, incorporated in 1990, operates in the pharmaceutical industry as a manufacturer and exporter of Active Pharmaceutical Ingredients (APIs), intermediates, and nutraceutical ingredients. The company’s operations are primarily divided into two business segments: Generic APIs and Custom Synthesis of APIs and intermediates for global innovator pharmaceutical companies. Divis Laboratories serves global export markets and is recognized as one of the top three global API manufacturers. It partners with 20 of the world’s leading pharmaceutical innovators. The company emphasizes backward integration and supply chain reliability, leveraging its expertise in chemistry and large-scale manufacturing processes. There are no subsidiaries or listed exchanges associated with the company in the provided facts.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 and dividend | 23 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 11 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 7 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 6 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and dividend | 17 May 2025 |
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.